Literature DB >> 30416802

Role of p16 deletion and BAP1 loss in the diagnosis of malignant mesothelioma.

Jing Liu1, Xuanzhi Liao1, Yingying Gu1, Lin Fu1, Jin Zhao1, Longguang Li1, Zhucheng Chen1, Juhong Jiang1.   

Abstract

Entities:  

Year:  2018        PMID： 30416802      PMCID： PMC6196170          DOI： 10.21037/jtd.2018.08.59

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN： 2072-1439            Impact factor:   2.895


× No keyword cloud information.
  40 in total

1.  Molecular pathways: targeting mechanisms of asbestos and erionite carcinogenesis in mesothelioma.

Authors:  Michele Carbone; Haining Yang
Journal:  Clin Cancer Res       Date:  2011-11-07       Impact factor: 12.531

2.  Homozygous deletion of p16INK4a and tobacco carcinogen exposure in nonsmall cell lung cancer.

Authors:  Kim S Kraunz; Heather H Nelson; Miriam Lemos; John J Godleski; John K Wiencke; Karl T Kelsey
Journal:  Int J Cancer       Date:  2006-03-15       Impact factor: 7.396

3.  Coexistence of p16/CDKN2A homozygous deletions and activating EGFR mutations in lung adenocarcinoma patients signifies a poor response to EGFR-TKIs.

Authors:  Juhong Jiang; Yingying Gu; Jing Liu; Ruibin Wu; Lin Fu; Jin Zhao; Yubao Guan
Journal:  Lung Cancer       Date:  2016-10-31       Impact factor: 5.705

4.  The nuclear deubiquitinase BAP1 is commonly inactivated by somatic mutations and 3p21.1 losses in malignant pleural mesothelioma.

Authors:  Matthew Bott; Marie Brevet; Barry S Taylor; Shigeki Shimizu; Tatsuo Ito; Lu Wang; Jenette Creaney; Richard A Lake; Maureen F Zakowski; Boris Reva; Chris Sander; Robert Delsite; Simon Powell; Qin Zhou; Ronglai Shen; Adam Olshen; Valerie Rusch; Marc Ladanyi
Journal:  Nat Genet       Date:  2011-06-05       Impact factor: 38.330

5.  BAP1 facilitates diagnostic objectivity, classification, and prognostication in malignant pleural mesothelioma.

Authors:  Stephanie M McGregor; Ryan Dunning; Elizabeth Hyjek; Wickii Vigneswaran; Aliya N Husain; Thomas Krausz
Journal:  Hum Pathol       Date:  2015-07-21       Impact factor: 3.466

6.  The diagnostic utility of p16 FISH and GLUT-1 immunohistochemical analysis in mesothelial proliferations.

Authors:  Sara E Monaco; Yongli Shuai; Mona Bansal; Alyssa M Krasinskas; Sanja Dacic
Journal:  Am J Clin Pathol       Date:  2011-04       Impact factor: 2.493

7.  The immunohistochemical diagnosis of mesothelioma: a comparative study of epithelioid mesothelioma and lung adenocarcinoma.

Authors:  Nelson G Ordóñez
Journal:  Am J Surg Pathol       Date:  2003-08       Impact factor: 6.394

8.  Utility of WT-1, p63, MOC31, mesothelin, and cytokeratin (K903 and CK5/6) immunostains in differentiating adenocarcinoma, squamous cell carcinoma, and malignant mesothelioma in effusions.

Authors:  Robert T Pu; Yijun Pang; Claire W Michael
Journal:  Diagn Cytopathol       Date:  2008-01       Impact factor: 1.582

9.  Guidelines for pathologic diagnosis of malignant mesothelioma: 2012 update of the consensus statement from the International Mesothelioma Interest Group.

Authors:  Aliya N Husain; Thomas Colby; Nelson Ordonez; Thomas Krausz; Richard Attanoos; Mary Beth Beasley; Alain C Borczuk; Kelly Butnor; Philip T Cagle; Lucian R Chirieac; Andrew Churg; Sanja Dacic; Armando Fraire; Francoise Galateau-Salle; Allen Gibbs; Allen Gown; Samuel Hammar; Leslie Litzky; Alberto M Marchevsky; Andrew G Nicholson; Victor Roggli; William D Travis; Mark Wick
Journal:  Arch Pathol Lab Med       Date:  2012-08-28       Impact factor: 5.534

10.  Loss of expression of BAP1 is very rare in non-small cell lung carcinoma.

Authors:  Juliana Andrici; Thomas R Parkhill; Jason Jung; Kathryn L Wardell; Brandon Verdonk; Arjun Singh; Loretta Sioson; Adele Clarkson; Nicole Watson; Amy Sheen; Mahtab Farzin; Christopher W Toon; Anthony J Gill
Journal:  Pathology       Date:  2016-04-21       Impact factor: 5.306
View more
  1 in total

1.  Synchronous Jejunal Sarcomatoid Carcinoma and Incidentally Associated Localized Peritoneal Malignant Mesothelioma.

Authors:  Mitsuhiro Tachibana; Masashi Nozawa; Kazuyasu Kamimura; Yutaka Tsutsumi
Journal:  Cureus       Date:  2022-06-24
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.